RADIANT-3 Trial: Everolimus in Pancreatic Neuroendocrine Tumors
0 Mga view
• 07/08/23
0
0
I-embed
administrator
Mga subscriber
Jonathan Strosberg, MD, Diane Reidy-Lagunes, MD, MS, and Rodney F. Pommier, MD, discuss results from the phase III RADIANT-3 trial that explored everolimus in patients with pancreatic neuroendocrine tumors.
For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento